Company registration number 09445478 (England and Wales)
MKW MEDICAL LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
MKW MEDICAL LIMITED
COMPANY INFORMATION
Directors
Mr M Koa-Wing
Mrs J A Koa-Wing
Secretary
Mrs J A Koa-Wing
Company number
09445478
Registered office
26 High Street
Rickmansworth
Hertfordshire
United Kingdom
WD3 1ER
Accountants
Xeinadin London Limited
8th Floor
Becket House
36 Old Jewry
London
EC2R 8DD
MKW MEDICAL LIMITED
CONTENTS
Page
Accountants' report
1
Balance sheet
2 - 3
Notes to the financial statements
4 - 8
MKW MEDICAL LIMITED
ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF MKW MEDICAL LIMITED FOR THE YEAR ENDED 31 MARCH 2025
- 1 -

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of MKW Medical Limited for the year ended 31 March 2025 which comprise, the balance sheet and the related notes from the company’s accounting records and from information and explanations you have given us.

 

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com/regulation.

This report is made solely to the board of directors of MKW Medical Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of MKW Medical Limited and state those matters that we have agreed to state to the board of directors of MKW Medical Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than MKW Medical Limited and its board of directors as a body, for our work or for this report.

It is your duty to ensure that MKW Medical Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of MKW Medical Limited. You consider that MKW Medical Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of MKW Medical Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Xeinadin London Limited
8th Floor
Becket House
36 Old Jewry
London
EC2R 8DD
23 December 2025
MKW MEDICAL LIMITED
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 2 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
873
2,112
Investments
4
14,786
-
0
15,659
2,112
Current assets
Debtors
5
17,958
10,088
Investments
6
-
0
47,060
Cash at bank and in hand
46,875
46,741
64,833
103,889
Creditors: amounts falling due within one year
7
(18,431)
(21,028)
Net current assets
46,402
82,861
Total assets less current liabilities
62,061
84,973
Provisions for liabilities
(167)
(402)
Net assets
61,894
84,571
Capital and reserves
Called up share capital
8
10
10
Profit and loss reserves
61,884
84,561
Total equity
61,894
84,571
MKW MEDICAL LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2025
31 March 2025
- 3 -

For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 23 December 2025 and are signed on its behalf by:
Mr M Koa-Wing
Director
Company registration number 09445478 (England and Wales)
MKW MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 4 -
1
Accounting policies
Company information

MKW Medical Limited is a private company limited by shares incorporated in England and Wales. The registered office is 26 High Street, Rickmansworth, Hertfordshire, United Kingdom, WD3 1ER.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recoverable.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and machinery
25% straight line
Fixtures & fittings
25% straight line
Computer equipment
33% straight line
1.4
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

MKW MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 5 -

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Financial instruments
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

MKW MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 6 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.8
Retirement benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

1.9
Leases
As lessee

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
1
1
MKW MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 7 -
3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 April 2024 and 31 March 2025
12,040
Depreciation and impairment
At 1 April 2024
9,928
Depreciation charged in the year
1,239
At 31 March 2025
11,167
Carrying amount
At 31 March 2025
873
At 31 March 2024
2,112
4
Fixed asset investments
2025
2024
£
£
Other investments other than loans
14,786
-
0
Movements in fixed asset investments
Investments
£
Cost or valuation
At 1 April 2024
-
Valuation changes
14,786
At 31 March 2025
14,786
Carrying amount
At 31 March 2025
14,786
At 31 March 2024
-
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
7,914
4,026
Other debtors
10,044
6,062
17,958
10,088
MKW MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 8 -
6
Current asset investments
2025
2024
£
£
Other investments
-
0
47,060
7
Creditors: amounts falling due within one year
2025
2024
£
£
Taxation and social security
16,515
18,699
Other creditors
1,916
2,329
18,431
21,028
8
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Orindary shares of £1 each
10
10
10
10
2025-03-312024-04-01falsefalsefalse23 December 2025CCH SoftwareCCH Accounts Production 2025.300No description of principal activityMr M Koa-WingMrs J A Koa-WingMrs J A Koa-Wing094454782024-04-012025-03-3109445478bus:Director12024-04-012025-03-3109445478bus:CompanySecretaryDirector12024-04-012025-03-3109445478bus:CompanySecretary12024-04-012025-03-3109445478bus:Director22024-04-012025-03-3109445478bus:RegisteredOffice2024-04-012025-03-31094454782025-03-31094454782024-03-3109445478core:OtherPropertyPlantEquipment2025-03-3109445478core:OtherPropertyPlantEquipment2024-03-3109445478core:CurrentFinancialInstrumentscore:WithinOneYear2025-03-3109445478core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3109445478core:WithinOneYear2025-03-3109445478core:WithinOneYear2024-03-3109445478core:CurrentFinancialInstruments2025-03-3109445478core:CurrentFinancialInstruments2024-03-3109445478core:ShareCapital2025-03-3109445478core:ShareCapital2024-03-3109445478core:RetainedEarningsAccumulatedLosses2025-03-3109445478core:RetainedEarningsAccumulatedLosses2024-03-3109445478core:ShareCapitalOrdinaryShareClass12025-03-3109445478core:ShareCapitalOrdinaryShareClass12024-03-3109445478core:PlantMachinery2024-04-012025-03-3109445478core:FurnitureFittings2024-04-012025-03-3109445478core:ComputerEquipment2024-04-012025-03-31094454782023-04-012024-03-3109445478core:OtherPropertyPlantEquipment2024-03-3109445478core:OtherPropertyPlantEquipment2024-04-012025-03-3109445478bus:OrdinaryShareClass12024-04-012025-03-3109445478bus:OrdinaryShareClass12025-03-3109445478bus:OrdinaryShareClass12024-03-3109445478bus:PrivateLimitedCompanyLtd2024-04-012025-03-3109445478bus:SmallCompaniesRegimeForAccounts2024-04-012025-03-3109445478bus:FRS1022024-04-012025-03-3109445478bus:AuditExemptWithAccountantsReport2024-04-012025-03-3109445478bus:FullAccounts2024-04-012025-03-31xbrli:purexbrli:sharesiso4217:GBP